Manufacturers:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) ir...respective of interval between the doses was 63.1%, based on a median follow-up of 80 days, but tended to be higher when this interval was longer. The data reviewed at this time support the conclusion that the known and potential benefits of ChAdOx1-S/nCoV-19 [recombinant] vaccine outweigh the known and potential risks.
more
This report provides an overview of the progress in the roll-out of COVID-19 vaccines in adults (aged 18 years and above) across EU/EEA Member States. It presents the number of vaccine doses distributed by manufacturers to each Member State for the different approved vaccines and the number of first..., second or unspecified doses administered to adult individuals overall, by age group and other selected target groups including healthcare workers (HCW) and residents in long-term care facilities (LTCF).
more
The authors review some common myths circulating about the vaccine and clear up confusion with reliable facts.
Many people have questions about the new coronavirus disease 2019 (COVID-19) vaccines. As vaccine recipients’ most-trusted source of information on vaccines, you play a critical role in helping them understand the importance of COVID-19 vaccination, as well as if and when it is likely to be recomm...ended for them.
The materials include proven communication strategies and tips for effectively setting expectations and addressing questions from COVID-19 vaccine recipients.
more
This document offers tools to help journalists practice responsible coverage of the pandemic using evidence-based information. It also proposes ways to approach coverage and encourages journalists to provide advice and solutions that can help reduce health risks and save lives.
22 July 2022. This document provides the case definitions for public health surveillance of COVID-19 in humans caused by SARS-COV-2 infection.
Actualizadas en el documento titulado «Vigilancia de salud pública en relación con la COVID-19» publicado el 16 de diciembre de 2020
Обновление рекомендаций по санитарно-эпидемиологическому надзору за COVID-19 от
16 декабря 2020 г
Actualisées dans « La surveillance de la santé publique dans le contexte de la COVID-19 », publié le 16 décembre 2020
March 9, 2021
Here you can find a collection of useful manuals, videos, infographics and resource platforms.
The category "Vaccine hesitancy & myths" will be updated regularly with new documents, videos and information material. Please check this category within the COVID-19
https://medbox.org/fi...lter/602505261716D/toolbox/vaccination-strategy#GO
more
Contact tracing – along with robust testing, isolation and care of cases – is a key strategy for interrupting chains of transmission of SARS-CoV-2 and reducing mortality associated with COVID-19.
El rastreo de contactos, junto con las pruebas diagnósticas sólidas, el aislamiento y la atención de casos, es una estrategia fundamental para interrumpir las cadenas de transmisión del SARS-CoV-2 y reducir la mortalidad causada por la COVID-19.
Основные аспекты обеспечения биологической безопасности в лабораторных условиях в связи с распространением вируса SARS-CoV
28 January 2021. The purpose of this document is to provide interim guidance on laboratory biosafety related to the testing of clinical specimens of patients.
A new report released today documents an “invisible wall” which has blocked migrants from accessing basic services since the start of the COVID-19 pandemic, and is now preventing them from accessing vaccines.